StockData
Orthofix Medical Inc. logo

Orthofix Medical Inc. (OFIX) stock

OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3049% below fair value
$7.17+0.23 (+3.31%)

Close on Nov 13, 2026Market cap $292.05MP/E –Yield –

Earnings

Orthofix Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$207.90M
+1.1% on a year earlier
Adjusted EPS, Q3 FY2026
-$0.15
-$0.57 a year earlier
Latest guidance
Lowered
Nov 9, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Orthofix Medical's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 23, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026before the open$207.90M+1.1%-$0.15–Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026before the open$210.90M+3.8%-$0.39–Release
Q1 FY2026ended Mar 31, 2026May 5, 2026before the open$196.70M+1.6%-$0.52–Release
Q4 FY2025ended Dec 31, 2025Feb 24, 2026before the open$219.90M+1.9%-$0.06–Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025before the open$205.60M+4.6%-$0.57–Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025before the open$203.10M+2.3%-$0.36–Release
Q1 FY2025ended Mar 31, 2025May 6, 2025before the open$193.60M+2.7%-$1.35–Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025before the open$215.70M+7.6%-$0.75–Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open$196.60M+6.8%-$0.71–Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$198.60M+6.2%-$0.88–Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open$188.60M+7.6%-$0.95–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Orthofix Medical's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Net salesFY2026$825.00M – $830.00M–NewNov 9, 2026
Net salesnon-GAAPFY2026$845.00M – $855.00M–NewAug 5, 2026
Net salesGAAPFY2026$850.00M – $860.00M–NewMay 5, 2026
Net salesFY2026$850.00M – $860.00M$850.00M – $860.00MReaffirmedApr 9, 2026
non-GAAP adjusted EBITDAnon-GAAPFY2026$95.00M – $98.00M$95.00M – $98.00MReaffirmedAug 5, 2026
Non-GAAP adjusted EBITDAnon-GAAPFY2026$86.00M – $88.00M$95.00M – $98.00MLoweredNov 9, 2026

Guidance vs results

The last range Orthofix Medical gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$810.00M – $814.00M$822.20MΣ4QAbove range
Q1 FY2023Revenue$166.00M – $170.00M$175.20MAbove range

Guidance history

Every forecast Orthofix Medical put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 9, 2026Non-GAAP adjusted EBITDAFY2026$86.00M – $88.00MLowered
Nov 9, 2026Net salesFY2026$825.00M – $830.00MNew
Aug 5, 2026non-GAAP adjusted EBITDAFY2026$95.00M – $98.00MReaffirmed
Aug 5, 2026Net salesFY2026$845.00M – $855.00MNew
May 5, 2026Non-GAAP adjusted EBITDAFY2026$95.00M – $98.00MNew
May 5, 2026Net salesFY2026$850.00M – $860.00MNew
Apr 9, 2026Non-GAAP adjusted EBITDAFY2026$95.00M – $98.00MReaffirmed
Apr 9, 2026Net salesFY2026$850.00M – $860.00MReaffirmed
Feb 24, 2026Non-GAAP adjusted EBITDAFY2026$95.00M – $98.00MNew
Feb 24, 2026Net salesFY2026$850.00M – $860.00MNew
Feb 24, 2026net sales CAGR2026 through 2028+6.5% – +7.5%–
Nov 4, 2025Pro forma non-GAAP adjusted EBITDAFY2025$84.00M – $86.00MNew
Nov 4, 2025Pro forma net salesFY2025$810.00M – $814.00MNew
Aug 5, 2025Pro forma non-GAAP adjusted EBITDAFY2025$82.00M – $86.00MReaffirmed
Aug 5, 2025Pro forma net salesFY2025$808.00M – $816.00MReaffirmed
May 6, 2025non-GAAP adjusted EBITDAFY2025$82.00M – $86.00MReaffirmed
May 6, 2025implied constant currency growthFY2025+5%New
May 6, 2025Net salesFY2025$808.00M – $816.00MNew
Feb 25, 2025Non-GAAP adjusted EBITDAFY2025$82.00M – $86.00MNew
Feb 25, 2025Net salesFY2025$818.00M – $826.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Orthofix Medical filed with the SEC as exhibits to Form 8-K or 6-K

  1. Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance
    Results
  2. Drive Profitable Growth Investor Presentation November 2026
    Results
  3. Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress
    Results
  4. Drive Profitable Growth Investor Presentation August 2026
    Results
  5. Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine
    Results
  6. Drive Profitable Growth Investor Presentation May 2026
    Results
  7. Orthofix Realigns Spine Leadership to Strengthen Focus and Execution
    Results
  8. Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and
    Results
  9. Drive Profitable Growth Investor Presentation February 2026
    Results
  10. Orthofix Reports Third Quarter 2025 Financial Results
    Results
  11. Clear Course for Profitable Growth Investor Presentation November 2025
    Results
  12. Orthofix Reports Second Quarter 2025 Financial Results
    Results
  13. Clear Course for Profitable Growth 2Q 2025 Earnings Call August 5, 2025
    Results
  14. Orthofix Reports First Quarter 2025 Financial Results
    Results
  15. Clear Course for Profitable Growth 1Q 2025 Earnings Call May 6, 2025
    Results

See a number that looks wrong?